Marcus Boehm - Jan 18, 2022 Form 4 Insider Report for Vyant Bio, Inc. (VYNT)

Role
Director
Signature
/s/ Andrew LaFrence, attorney-in-fact
Stock symbol
VYNT
Transactions as of
Jan 18, 2022
Transactions value $
$7,500
Form type
4
Date filed
1/20/2022, 08:20 PM
Previous filing
Dec 7, 2021
Next filing
Apr 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Award $7.5K +5.73K $1.31 5.73K Jan 18, 2022 Direct F1
holding VYNT Common Stock, $0.0001 par value 129K Jan 18, 2022 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 18, 2022, the Reporting Person was granted 5,725 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2023, so long as Reporting Person remains a director though that date.